Latest Bleeding Stories
The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 Years CAMBRIDGE, MA, March 24, 2014 /CNW/ -
The Firm is investigating Pradaxa lawsuits on behalf of individuals who allegedly suffered serious episodes of internal bleeding, allegedly due to their use of the blood thinner. New
The DrugRisk Center is the largest source on the Web for information on prescription drug research, side effects and legal news.
Defective blood coagulation is one of the leading causes of preventable death in patients who have suffered trauma or undergone surgery.
WESTPORT, Conn., Feb. 25, 2014 /PRNewswire/ -- TriStar Wellness Solutions®, Inc.
The attorneys at Bernstein Liebhard LLP are evaluating potential Pradaxa lawsuit claims from individuals who may have experienced serious episodes of internal bleeding caused by the anti-coagulant.
- The PROTECT VIII study met its primary efficacy and safety objectives for the treatment of patients with hemophilia A WHIPPANY, N.J., Feb.
The Firm is evaluating Pradaxa lawsuits on behalf of individuals who suffered cerebral hemorrhage, gastrointestinal bleeding, and other serious bleeding events, allegedly due to Pradaxa.
http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.